Doctors Best at Choosing Heart Treatment
Posted on: Wednesday, 30 August 2006, 18:00 CDT
Doctors know best when it comes to treating coronary artery disease with angioplasty or surgery, says the University of Sao Paulo in Brazil.
University of Sao Paulo Medical School researchers reviewed data collected during the Medicine, Angioplasty or Surgery Study II (MASS II) to determine how physician-recommended care affected patient outcomes one year after treatment.
All patients were diagnosed with severe coronary artery disease affecting at least two blood vessels but not yet causing a loss of heart function. Coronary artery disease occurs when a buildup of cholesterol in the arteries prevents oxygen-rich blood from nourishing the heart muscle.
We still currently do not know which is the best therapeutic option for patients with multivessel chronic coronary artery disease and a normal ventricular function, said senior author Dr. Whady Hueb, a cardiologist at the University of Sao Paulo Heart Institute.
I think our study offers additional information and reassurance for both doctors and patients that, at the end of the decision-making process, what the doctor and patient agree is the best option in most cases really is the best option.
The findings are published in the Journal of the American College of Cardiology.
Source: United Press International
Related Articles
- Improving Treatment Of Patients With Heart Attack
- Houston Northwest Medical Center Receives American Heart Association's Get With The Guidelines Gold Performance Achievement Award for Heart Failure and Coronary Artery Disease
- Abbott Initiates U.S. Study of Absolute Pro(TM) Peripheral Stent System for Iliac Artery Disease
- Arterial disease pain helped by exercise
- Vermillion and Collaborators Discover Protein Biomarker Associated With Peripheral Artery Disease
- African-Americans Have Same Risk As Pack-a-Day Smokers for Developing Peripheral Arterial Disease, a Marker for Heart Attack and Stroke
- Results of exercise test may predict death in patients with coronary artery disease
- Noninvasive Diagnosis of Coronary Artery Disease in Patients With Diabetes By Dobutamine Stress Real-Time Myocardial Contrast Perfusion Imaging
- Presence of the Metabolic Syndrome Does Not Impair Coronary Collateral Vessel Formation in Patients With Documented Coronary Artery Disease
- Pfizer's Norvasc Demonstrates Significant Reductions in Major Cardiovascular Events in Patients With Coronary Artery Disease
 |
 |
User Comments (0)
RSS Feeds